Catalyst Wire Dossier Catalyst Wire Dossier

Fampridine-Sustained Release

dalfampridine · Acorda Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fampridine-Sustained Release, covering 2014-02-05 to 2014-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Oral Fampridine-Sustained Release (SR) for the Treatment of Spasticity Resulting From Spinal Cord Injury [Phase 3]

See pricing